$1.60 -$0.03 (0.0%)

03:38 PM EDT on 05/24/19

Neos Therapeutics (NASDAQ:NEOS)

CAPS Rating: No stars

Current Price $1.60 Mkt Cap $115.3M
Open $1.65 P/E Ratio 0.00
Prev. Close $1.60 Div. (Yield) $0.00 (0.0%)
Daily Range $1.60 - $1.68 Volume 36,335
52-Wk Range $1.57 - $3.62 Avg. Daily Vol.

Caps

How do you think NASDAQ:NEOS will perform against the market?

Add Stock to CAPS Watchlist

All Players

2 Outperform
1 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:NEOS Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:NEOS VS S&P 500 (SPY)

NASDAQ:NEOS Summary

Fools bullish on NASDAQ:NEOS are also bullish on:

Fools bearish on NASDAQ:NEOS are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about NEOS.

Recs

0
Member Avatar OklaBoston (37.06) Submitted: 5/15/2019 3:10:42 PM : Outperform Start Price: $1.84 NASDAQ:NEOS Score: -12.27

Shrinking deficit and much senior officer open market buying since it fell below $10.00.

Leaderboard

Find the members with the highest scoring picks in NEOS.

Score Leader

swhaze

swhaze (< 20) Score: +133.68

The Score Leader is the player with the highest score across all their picks in NEOS.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
swhaze < 20 2/8/2016 Underperform 1Y $8.57 -81.33% +52.35% +133.68 0 Comment
OklaBoston 37.06 5/15/2019 Outperform 3Y $1.84 -13.04% -0.77% -12.27 1 Comment
Opaspicks 30.74 10/2/2015 Outperform 3Y $20.25 -92.10% +48.14% -140.24 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NEOS.

Advertisement